Researchers at the University of Chicago Medicine Comprehensive Cancer Center established “proof-of-concept” for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.
Pharmalittle: We’re reading about a Merck deal, GSK cancer drug data, and more
Rise and shine, everyone, another busy day is on the way. We can tell by the sound of the motor vehicles passing by our window